Mariam Alatrach

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( <scp>EDICT</scp> )

Olga Lavynenko, Muhammad Abdul‐Ghani, Mariam Alatrach et al. · Diabetes Obesity and Metabolism · 2022 · 40 citations

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

Mariam Alatrach, Nitchakarn Laichuthai, Robert Martinez et al. · Diabetes · 2020 · 33 citations · Full text

Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

Carolina Solis‐Herrera, Giuseppe Daniele, Mariam Alatrach et al. · Diabetes Care · 2020 · 27 citations · Full text

Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG

Mariam Alatrach, Christina Agyin, Rucha Mehta et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 19 citations · Full text

Decreased basal hepatic glucose uptake in impaired fasting glucose

Mariam Alatrach, Christina Agyin, John M. Adams et al. · Diabetologia · 2017 · 15 citations · Full text

Metabolic Syndrome, Hepatology, Liver Physiology +9